Liping Yu

Johns Hopkins University

$374,155

Attributed

$826,778

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $235.4K · FY2020–24

$250K$187.5K$125K$62.5K$0

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$826,778 · 3

By mechanism

R21$427,625 · 1

R56$399,153 · 2

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Stephen J Gould$8,380,884
Peter C Agre$14,013,185
Rejji Kuruvilla$11,091,315
Leslie P Plotnik$0
Richard J Jones$17,555,212

Others in their field

Other Emerging Leaders on “Serum”

James Dale Berry · Brigham And Women'S Hospital$25,017,559
Maria C Carrillo · Indiana University Indianapolis$19,445,642
Amit Singal · Ut Southwestern Medical Center$13,798,031
Leonard Freedman · Leidos Biomedical Research, Inc.$12,916,531
Quy Phung · Leidos Biomedical Research, Inc.$12,889,396
Xinhua Li · Nano Terra, Inc.$11,941,250

Research focus

SerumCohortPrevalenceBeta CellDisease ProgressionIsletEpitopesMembraneAutoantibodiesBindingInsulin Dependent Diabetes Mellitus OnsetAutoantigensInsulinInsulin-Dependent Diabetes MellitusChildBirthAutoimmune DiseasesExtracellularGeneral PopulationAppearanceCell InjuryB-LymphocytesDisease MarkerBiological Markers

Grant awards (4)

ZnT8-specific bioanalytical tools for probing autoimmune destruction of pancreatic beta-cells in type-1 diabetes$235,403

R56 · FY2024 · DK

Autoantibodies targeting deamidated epitopes in insulinoma antigen 2 as biomarkers in T1D$194,375

R21 · FY2022 · AI · contact PI

Autoantibodies targeting deamidated epitopes in insulinoma antigen 2 as biomarkers in T1D$233,250

R21 · FY2021 · AI · contact PI

Autoantibodies directed to islet cell surface antigens and their pathologic roles in type-1 diabetes$163,750

R56 · FY2020 · DK